Target intelligence / Profile preview

DNA base

Molecular classification
Other
01

Overview

DNA bases—also known as nucleotide bases, nucleobases, or nitrogenous bases—are the fundamental building blocks that make up the genetic code within deoxyribonucleic acid (DNA). There are four canonical DNA bases: adenine (A), thymine (T), guanine (G), and cytosine (C)[1][2][3][9]. These molecules form specific pairs through hydrogen bonding—adenine with thymine and guanine with cytosine—which is essential for the double helix structure of DNA[1][5]. The sequence of these bases encodes genetic information used in protein synthesis and cellular function[2][6]. While individual drugs may target processes involving these molecules, "DNA base" itself is not a therapeutic target like a receptor or enzyme; rather, it is a chemical component within larger biological macromolecules. The term "DNA bases" refers to multiple small molecules rather than a single defined molecular entity. Note: This entry is marked as incorrect because "DNA bases" does not refer to a single therapeutic target but instead describes several small molecule components found within nucleic acids. It lacks specificity required for structured drug-target databases.

Other names
nucleotide basenucleobasenitrogenous base
02

Mechanism of action

Inhibition of DNA synthesis by incorporation of analogs Induction of mutations or strand breaks by chemical modification

03

Biological functions

Genetic information storageBase pairing in nucleic acidsEncoding of genetic instructions
04

Disease associations

Other (mutations or modifications in DNA bases can contribute to diseases such as cancer)
05

Safety considerations

Off-target effects and toxicity from drugs that interact with DNA bases
06

Interacting drugs

Nucleoside analogs (e.g., 5-fluorouracil, cytarabine)

2 more in the full profile.

07

Biomarkers

Modified bases as biomarkers for oxidative stress or mutagenesis (e.g., 8-hydroxydeoxyguanosine)

Beyond the preview

Go deeper on DNA base.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA base.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call